CD8A and neuroblastoma: While, we have not tested the impact of Syk inhibition on DC’s capacity to generate CD8+ T cell responses, we found the predominant role of macrophage Syk in controlling tumor growth and inhibition of adaptive immune responses in the neuroblastoma model.